BiotechTube
Home/HilleVax/David Socks
DS

David Socks

Chief Financial Officer

HilleVax

Therapeutic Areas

Infectious DiseaseGastroenterology

HilleVax Pipeline

DrugIndicationPhase
HIL-214Prevention of moderate-to-severe acute gastroenteritis caused by norovirus infectionPhase 2b/3

Leadership Team at HilleVax

RH
Rob Hershberg
Chairman and Chief Executive Officer
SM
Shane Maltbie
Chief Development Officer
AB
A. Bruce Montgomery
Chief Medical Officer
GD
Gary Dubin
Former Chief Medical Officer (key architect)
TF
Tara Fitzgerald
Chief Technical Officer
View full HilleVax profile